COVID-19 natural history, complications and prognosis: Difference between revisions
Jump to navigation
Jump to search
| Line 9: | Line 9: | ||
=== Natural History === | === Natural History === | ||
* The clinical course of the disease consists of three major patterns: | * The clinical course of the disease consists of three major patterns:<ref name="HeymannShindo2020">{{cite journal|last1=Heymann|first1=David L|last2=Shindo|first2=Nahoko|title=COVID-19: what is next for public health?|journal=The Lancet|volume=395|issue=10224|year=2020|pages=542–545|issn=01406736|doi=10.1016/S0140-6736(20)30374-3}}</ref> | ||
** Mild illness with upper respiratory tract presenting symptoms | ** Mild illness with upper respiratory tract presenting symptoms | ||
** Non-life-threatening pneumonia | ** Non-life-threatening pneumonia | ||
Revision as of 22:00, 12 March 2020
|
COVID-19 Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
COVID-19 natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of COVID-19 natural history, complications and prognosis |
|
FDA on COVID-19 natural history, complications and prognosis |
|
CDC on COVID-19 natural history, complications and prognosis |
|
COVID-19 natural history, complications and prognosis in the news |
|
Blogs on COVID-19 natural history, complications and prognosis |
|
Risk calculators and risk factors for COVID-19 natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Natural History, Complications, and Prognosis
Natural History
- The clinical course of the disease consists of three major patterns:[1]
- Mild illness with upper respiratory tract presenting symptoms
- Non-life-threatening pneumonia
- Severe pneumonia with acute respiratory distress syndrome (ARDS) that begins with mild symptoms for 7 - 8 days and progressing to rapid deterioration and ARDS requiring advanced life support
References
- ↑ Heymann, David L; Shindo, Nahoko (2020). "COVID-19: what is next for public health?". The Lancet. 395 (10224): 542–545. doi:10.1016/S0140-6736(20)30374-3. ISSN 0140-6736.